CCR4 and tropical spastic paraparesis: Furthermore, in HAM/TSP patients who received anti-CCR4 antibody therapy, low CSF CXCL10 levels were maintained for about 10 months; during this period, clinical improvement was maintained (Sato et al., 2018a).